SG11201707469WA - Substituted tricyclic heterocyclic compounds - Google Patents
Substituted tricyclic heterocyclic compoundsInfo
- Publication number
- SG11201707469WA SG11201707469WA SG11201707469WA SG11201707469WA SG11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA SG 11201707469W A SG11201707469W A SG 11201707469WA
- Authority
- SG
- Singapore
- Prior art keywords
- heterocyclic compounds
- tricyclic heterocyclic
- substituted tricyclic
- substituted
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562134769P | 2015-03-18 | 2015-03-18 | |
| PCT/US2016/022737 WO2016149436A1 (en) | 2015-03-18 | 2016-03-17 | Substituted tricyclic heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201707469WA true SG11201707469WA (en) | 2017-10-30 |
Family
ID=55640932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201707469WA SG11201707469WA (en) | 2015-03-18 | 2016-03-17 | Substituted tricyclic heterocyclic compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10189840B2 (en) |
| EP (1) | EP3271360B1 (en) |
| JP (1) | JP6793657B2 (en) |
| KR (1) | KR102654709B1 (en) |
| CN (1) | CN107635993B (en) |
| AU (1) | AU2016233288A1 (en) |
| BR (1) | BR112017019773A2 (en) |
| CA (1) | CA2980159A1 (en) |
| EA (1) | EA032315B1 (en) |
| ES (1) | ES2797805T3 (en) |
| IL (1) | IL254424A0 (en) |
| MX (1) | MX2017011434A (en) |
| SG (1) | SG11201707469WA (en) |
| WO (1) | WO2016149436A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201792054A1 (en) | 2015-03-18 | 2018-01-31 | Бристол-Майерс Сквибб Компани | HETEROCYCLIC COMPOUNDS APPLICABLE AS TNF INHIBITORS |
| MX2017011433A (en) | 2015-03-18 | 2017-11-10 | Bristol Myers Squibb Co | Tricyclic heterocyclic compounds useful as inhibitors of tnf. |
| WO2016168633A1 (en) | 2015-04-17 | 2016-10-20 | Abbvie Inc. | Indazolones as modulators of tnf signaling |
| UY36630A (en) | 2015-04-17 | 2016-11-30 | Abbvie Inc | TRICYCLIC MODULATORS OF TNF SIGNALING |
| EP3286195A1 (en) | 2015-04-17 | 2018-02-28 | AbbVie Inc. | Indazolones as modulators of tnf signaling |
| GB201510758D0 (en) | 2015-06-18 | 2015-08-05 | Ucb Biopharma Sprl | Novel TNFa structure for use in therapy |
| US10335392B2 (en) | 2015-08-03 | 2019-07-02 | Bristol-Myers Squibb Company | Cyclic compounds useful as modulators of TNF α |
| GB201621907D0 (en) | 2016-12-21 | 2017-02-01 | Ucb Biopharma Sprl And Sanofi | Antibody epitope |
| CA3055863A1 (en) | 2017-03-15 | 2018-09-20 | Ucb Biopharma Sprl | Fused pentacyclic imidazole derivatives as modulators of tnf activity |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6038397B2 (en) * | 1980-03-06 | 1985-08-31 | エスエス製薬株式会社 | Thiazinoimidazole derivative and method for producing the same |
| US6369235B1 (en) | 1997-02-25 | 2002-04-09 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection |
| JP2003512467A (en) * | 1999-10-27 | 2003-04-02 | ノバルティス アクチエンゲゼルシャフト | Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use |
| US7601846B2 (en) | 2001-06-26 | 2009-10-13 | The Regents Of The University Of California | Compounds having activity as inhibitors of apoptosis |
| US20050113397A1 (en) | 2002-01-31 | 2005-05-26 | Makoto Takemura | Imidazo[1,2-a]pyridine derivative |
| WO2004050035A2 (en) | 2002-12-03 | 2004-06-17 | Isis Pharmaceuticals, Inc. | Benzimidazoles and analogs thereof as antivirals |
| US20050124638A1 (en) | 2003-12-08 | 2005-06-09 | Swayze Eric E. | Benzimidazoles and analogs thereof as antivirals |
| AU2008267443A1 (en) * | 2007-06-26 | 2008-12-31 | Sanofi-Aventis | A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
| FR2919610B1 (en) * | 2007-08-02 | 2009-10-16 | Sanofi Aventis Sa | TRICYCLIC N-HETEROARYL-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| US20110009403A1 (en) | 2007-10-05 | 2011-01-13 | S*Bio Pte Ltd. | 2-morpholinylpurines as inhibitors of pi3k |
| JP2009227599A (en) | 2008-03-21 | 2009-10-08 | Daiichi Sankyo Co Ltd | Imidazopyridazine derivative |
| CN101717397B (en) | 2008-10-09 | 2012-11-28 | 中国科学院上海药物研究所 | Substituted pyridino-[2',1':2,3] imidazo[4,5-c] isoquinolone compounds, method for synthesizing same, use of same and medicinal composition having same |
| KR20110098827A (en) * | 2008-12-19 | 2011-09-01 | 브리스톨-마이어스 스큅 컴퍼니 | Carbazole carboxamide compounds useful as kinase inhibitors |
| CA2756137C (en) | 2009-03-23 | 2015-11-24 | Siemens Medical Solutions Usa, Inc. | Imaging agents for detecting neurological disorders |
| US8691187B2 (en) | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
| WO2012148550A1 (en) | 2011-02-25 | 2012-11-01 | Myrexis, Inc. | Prodrugs of therapeutic compounds |
| EP2527344A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
| EP2858983B1 (en) * | 2012-06-11 | 2018-04-18 | UCB Biopharma SPRL | Tnf-alpha modulating benzimidazoles |
| GB201212513D0 (en) | 2012-07-13 | 2012-08-29 | Ucb Pharma Sa | Therapeutic agents |
| CA2877550C (en) | 2012-07-13 | 2020-09-08 | Ucb Biopharma Sprl | Imidazopyridine derivatives as modulators of tnf activity |
| GB201321743D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| CN105814052B (en) | 2013-12-09 | 2018-01-12 | Ucb生物制药私人有限公司 | Imidazopyridine derivatives as TNF active regulators |
| GB201321742D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321744D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321735D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
| GB201321741D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321739D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321737D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
| GB201321738D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
| CA2931589C (en) | 2013-12-09 | 2022-01-04 | Ucb Biopharma Sprl | Fused bicyclic heteroaromatic derivatives as modulators of tnf activity |
| GB201321745D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321746D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| CN113248506A (en) | 2014-10-06 | 2021-08-13 | 西格诺药品有限公司 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith |
| EA201792054A1 (en) | 2015-03-18 | 2018-01-31 | Бристол-Майерс Сквибб Компани | HETEROCYCLIC COMPOUNDS APPLICABLE AS TNF INHIBITORS |
| MX2017011433A (en) | 2015-03-18 | 2017-11-10 | Bristol Myers Squibb Co | Tricyclic heterocyclic compounds useful as inhibitors of tnf. |
-
2016
- 2016-03-17 BR BR112017019773-1A patent/BR112017019773A2/en not_active Application Discontinuation
- 2016-03-17 KR KR1020177029449A patent/KR102654709B1/en active IP Right Grant
- 2016-03-17 MX MX2017011434A patent/MX2017011434A/en unknown
- 2016-03-17 AU AU2016233288A patent/AU2016233288A1/en not_active Abandoned
- 2016-03-17 US US15/558,692 patent/US10189840B2/en active Active
- 2016-03-17 SG SG11201707469WA patent/SG11201707469WA/en unknown
- 2016-03-17 CA CA2980159A patent/CA2980159A1/en not_active Abandoned
- 2016-03-17 CN CN201680026733.XA patent/CN107635993B/en active Active
- 2016-03-17 ES ES16712645T patent/ES2797805T3/en active Active
- 2016-03-17 EP EP16712645.7A patent/EP3271360B1/en active Active
- 2016-03-17 JP JP2017549092A patent/JP6793657B2/en active Active
- 2016-03-17 EA EA201792034A patent/EA032315B1/en not_active IP Right Cessation
- 2016-03-17 WO PCT/US2016/022737 patent/WO2016149436A1/en active Application Filing
-
2017
- 2017-09-11 IL IL254424A patent/IL254424A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2797805T3 (en) | 2020-12-03 |
| JP2018508553A (en) | 2018-03-29 |
| BR112017019773A2 (en) | 2018-05-15 |
| JP6793657B2 (en) | 2020-12-02 |
| KR20170129810A (en) | 2017-11-27 |
| EP3271360A1 (en) | 2018-01-24 |
| EA032315B1 (en) | 2019-05-31 |
| IL254424A0 (en) | 2017-11-30 |
| CA2980159A1 (en) | 2016-09-22 |
| EA201792034A1 (en) | 2018-03-30 |
| MX2017011434A (en) | 2018-01-25 |
| AU2016233288A1 (en) | 2017-11-09 |
| KR102654709B1 (en) | 2024-04-03 |
| EP3271360B1 (en) | 2020-04-22 |
| US20180111936A1 (en) | 2018-04-26 |
| CN107635993A (en) | 2018-01-26 |
| US10189840B2 (en) | 2019-01-29 |
| CN107635993B (en) | 2020-05-22 |
| WO2016149436A1 (en) | 2016-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201807249B (en) | Heterocyclic compound | |
| HK1223100A1 (en) | Heterocyclic compounds | |
| IL247018A0 (en) | Heterocyclic compound | |
| IL248991B (en) | Substituted dihydroisoquinolinone compounds | |
| IL253361B (en) | Tricyclic spiro compound | |
| IL254424A0 (en) | Substituted tricyclic heterocyclic compounds | |
| HK1251465A1 (en) | Compositions comprising tricyclic heterocyclic compounds | |
| IL285105A (en) | Heterocyclic compound | |
| IL254320A0 (en) | Organic compounds | |
| EP3693360C0 (en) | Heterocyclic compounds | |
| HUE049482T2 (en) | Novel heterocyclic compound | |
| IL254890B (en) | Heterocyclic compound | |
| IL249907A0 (en) | Tricyclic triazolic compounds | |
| IL262448B (en) | Substituted bicyclic heterocyclic compounds | |
| GB201521758D0 (en) | Organic compounds | |
| GB201501824D0 (en) | Organic compounds | |
| IL266099A (en) | Heterocyclic compound | |
| HUP1700522A1 (en) | Tricyclic compounds |